Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Apigenin.
Apigenin is a bioactive trihydroxyflavone that functions as a potent GABA-A receptor ligand and CD38 inhibitor, primarily utilized for its anxiolytic, neuroprotective, and NAD+ boosting properties.
5280443
270.24 g/mol
1.7
5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Apigenin across standard consumer modalities.
Apigenin's low aqueous solubility necessitates micronization or the use of lipid-based excipients to ensure consistent dissolution and absorption from dry powder capsules.
The hydrophobic nature of apigenin can lead to uneven dispersion and crystallization within the pectin matrix, potentially affecting texture and dosage uniformity.
The high effective dose required for certain therapeutic outcomes often exceeds the 20-30mg payload capacity of standard thin-film oral strips.
Ready to launch a product featuring Apigenin? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Apigenin extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Apigenin payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation